WntResearch is active in biotechnology. Today the main focus is on the development of drug candidates for various metastatic forms of cancer. The research is focused on studying the bodily-specific protein WNT-5a, which has been found to play a crucial role in the proliferation of tumour cells. The products are licensed to various stakeholders in the industry. The head office is in Malmö.

Quotes for WntResearch AB

Right Now

+/-
-0.12
%
-2,21%
Latest
5.3
High
5.4
Low
4.99
Volume
92 159
Turnover (SEK)
472 078
Value (MSEK)
134,5

Board

CEO

  • Peter Morsing

Chairman Of The Board

  • Gudrun Anstrén

Board

  • Jan Nilsson
  • Martin Olovsson
  • Peter Ström
  • Tommy Andersson

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 12,22 12,22 2019-12-31
Nordnet Pensionsförsäkring 10,15 10,15 2019-12-31
Kjell Stenberg 5,97 5,97 2019-12-31
Tommy Andersson 4,24 4,24 2019-12-31
Lars-Erik Forsgårdh 2,14 2,14 2019-12-31
Leif Bertils 1,13 1,13 2019-12-31
Nils Qvarner 1,10 1,10 2019-12-31
Bostadsrättsbyggarna Svenska Holding AB 0,89 0,89 2019-12-31
Swedbank Försäkring 0,76 0,76 2019-12-31
Livförsäkringsbolaget Skandia 0,61 0,61 2019-12-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2020-05-19 Årsstämma 2019

  • 2020-05-19 Delårsrapport 2020-Q1

  • 2020-08-13 Delårsrapport 2020-Q2

  • 2020-11-12 Delårsrapport 2020-Q3